Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 41 - 60 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Rentschler Biopharma SE | Rentschler Biopharma Inc. | Rentschler Biopharma Inc.

Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Milestone Pharmaceuticals Inc.

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Akoya Biosciences, Inc.

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Taysha Gene Therapies, Inc.

NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: NewAmsterdam Pharma B.V.

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Mineralys Therapeutics, Inc.

Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Protara Therapeutics, Inc.

Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Immutep Limited

Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Amolyt Pharma SAS

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Daré Bioscience, Inc.

Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Lisata Therapeutics, Inc.

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: LifeMD, Inc

The Canadian Dermatology Association (CDA) Announces the Launch of the 2024 Shade Structure Grant Program

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Canadian Dermatology Association

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: iCAD, Inc.

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Science 37, Inc.

Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer

Read more ››

By: GlobeNewswire - 02 May 2024

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: PDS Biotechnology Corporation

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Intuity Medical, Inc

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: EDAP TMS S.A.

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Read more ››

By: GlobeNewswire - 02 May 2024

Related companies: Allarity Therapeutics, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

to the top ↑